Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
10/2012
10/31/2012CN102151242B In-situ gel slow-release preparation for anti-tuberculosis drugs and preparation method thereof
10/31/2012CN102145092B Chinese medical composition capable of dispelling wind and relieving fever and preparation method
10/31/2012CN102119978B Composition for relieving exterior syndrome and clearing away heat and toxic materials, and preparation method and detection method thereof
10/31/2012CN102068621B Chinese medicinal composition for treating infantile cold and fever and preparation method thereof
10/31/2012CN102058768B Traditional Chinese medicine composition for clearing lung, eliminating phlegm and stopping cough and asthma, and preparation method thereof
10/31/2012CN102040574B Hydroquinone compound with anti-HCV (Hepatitis C Virus) activity and preparation method thereof
10/31/2012CN102038775B Preparation method of traditional Chinese medicine composition for treating cold in children
10/31/2012CN102018665B Strictosamide injection and preparation method thereof
10/31/2012CN102000092B New application of sulfadiazine sodium in preparing medicine for preventing or treating Bombyx mori septicemia
10/31/2012CN101980711B Aromatic heterocyclic fused indolobenzadiazepine HCV NS5B inhibitors
10/31/2012CN101955462B Fenticonazole nitrate, preparation of levorotatory form and dextrorotatory form and application of levorotatory form in preparing antifungal medicaments
10/31/2012CN101933976B Method for preparing nanoemulsion from high-efficient active sites of fructus forsythiae essential oil
10/31/2012CN101919961B Drug composition for treating cold and preparation method thereof
10/31/2012CN101732446B Emulsified oil for treating tinea pedis and preparation method thereof
10/31/2012CN101723896B Tyrosine derivative histone deacetylases inhibitor and application thereof
10/31/2012CN101687884B Macrolactone derivatives
10/31/2012CN101641095B Combination medicaments for treating bacterial infections
10/31/2012CN101590105B Chinese medicinal herb extract for inducing immune cells to generate interferon and activated TOLL-like receptors and preparation method thereof
10/31/2012CN101575330B Novel voriconazole broad-spectrum antifungal medicine compound, broad-spectrum antifungal medicine composition and application thereof
10/31/2012CN101575320B Water-soluble triazole antifungal compound
10/31/2012CN101481397B Novel kanamycin A derivative, and preparation and use thereof
10/31/2012CN101234193B Stable water solution containing recombination human serum albumin fusion interferon
10/31/2012CN101208104B Nipah virus vaccines
10/31/2012CN101023947B Methods and compositions for bactericide, bacteriostatic and anti-inflammation
10/30/2012US8299213 Synthetic or natural peptides binding protein phosphatase 2A, identification method and uses
10/30/2012US8299116 CCI-779 concentrate formulations
10/30/2012US8299094 Hepatitis C virus inhibitors
10/30/2012US8299051 Beta-lactamase inhibitory compounds
10/30/2012US8299038 Methods and compositions for treating hepatitis C virus
10/30/2012US8299020 Antimicrobial peptides and methods of their use
10/30/2012US8298817 Vector
10/30/2012US8298551 Streptococcus pyogenes antigens and corresponding DNA fragments
10/30/2012US8298541 Live attenuated virus vaccines for La Crosse virus and other Bunyaviridae
10/30/2012CA2684402C Methods and compositions for treatment of disorders associated with chlamydial and similar bacterial infection
10/30/2012CA2675528C Oral disinfectant, and food additive comprising the disinfectant
10/30/2012CA2565889C Oral flora-improving agent, antibacterial agent and growth promoter
10/30/2012CA2506244C Methods for inhibiting viral replication in vivo
10/30/2012CA2498731C .beta.-l-2'-deoxynucleosides for the treatment of resistant hbv strains and combination therapies
10/30/2012CA2467580C Use of lipoxin analogs to promote cell defense against gram-negative infections
10/30/2012CA2445938C Hepatitis c inhibitor tri-peptides
10/30/2012CA2433962C Antibacterial clarithromycin compositions and processes for making the same
10/30/2012CA2399790C Cd40 ligand adjuvant for respiratory syncytial virus
10/30/2012CA2215161C Proteinase k resistant surface protein of neisseria meningitidis
10/26/2012WO2012145758A1 Fusion peptide designed to reduce plaque bacteria and yeast in the oral cavity
10/26/2012WO2012145728A1 Benzothiazole compounds and their pharmaceutical use
10/26/2012WO2012145680A2 Anti-microbial peptides and uses therefore
10/26/2012WO2012145666A1 Peptide and conjugate vaccines for fungal infections
10/26/2012WO2012145577A1 Adjuvanted rabies vaccine with improved viscosity profile
10/26/2012WO2012145509A2 Adeno-associated-virus rep sequences, vectors, and viruses
10/26/2012WO2012145307A1 Method of inhibiting harmful microorganisms and barrier-forming composition therefor
10/26/2012WO2012144934A1 Composition for the manufacture of sporicidal peracetic acid compositions, method (variants) and set for implementing same
10/26/2012WO2012144892A1 Medical use for acidic cannabinoids
10/26/2012WO2012144754A2 Composition containing a galla rhois extract having virus inhibitory effects or a compound isolated therefrom as an active ingredient, and uses thereof
10/26/2012WO2012144752A1 Phenyl-isoxazol derivatives and preparation process thereof
10/26/2012WO2012144619A1 Chronic hepatic diseases therapeutic agent for oral administration
10/26/2012WO2012144519A1 Granules in liquid dosage form
10/26/2012WO2012143416A2 Novel compounds
10/26/2012WO2012143017A1 The use of orobancheace extract for the treatment of hepatitis c virus and nonalcoholic fatty liver disease
10/26/2012WO2012142960A1 Erythromycin ethylsuccinate crystalline hydrate, preparation and uses thereof
10/26/2012WO2012142959A1 High purity of caspofungin or salts thereof, and preparation method therefor, and use thereof
10/26/2012WO2012142958A1 Tigecycline crystalline hydrate and preparation method therefor and use thereof
10/26/2012WO2012142855A1 Antibiotic peptide and preparation method therefor and application thereof
10/26/2012WO2012142724A1 New low side effect pharmaceutical composition containing antituberculosis drugs
10/26/2012WO2012142671A1 Aromatic amides and uses thereof
10/26/2012WO2012116010A3 Antibiotic tolerance inhibitors
10/26/2012WO2012110636A3 Carrier peptides for cell delivery
10/26/2012WO2012108794A3 1,2,4-triazol-3-ylthioglycolic acid derivatives for use in therapy
10/26/2012WO2012096926A3 Method for delivering agents into cells using bacterial toxins
10/26/2012WO2012056387A3 A dermaceutical gel made using sodium fusidate and a process to make it
10/26/2012WO2011113606A8 Anti-infective compounds
10/26/2012WO2011085990A8 Anti - infective pyrido (1,2 -a) pyrimidines
10/26/2012CA2833766A1 Modulation of hepatitis b virus (hbv) expression
10/26/2012CA2833409A1 Streptococcus bacteriophage lysins for detection and treatment of gram positive bacteria
10/26/2012CA2833377A1 Benzothiazole compounds and their pharmaceutical use
10/26/2012CA2832854A1 Method of inhibiting harmful microorganisms and barrier-forming composition therefor
10/26/2012CA2831650A1 Medical products for use in conditions related to microbial infections in the upper aerodigestive tract
10/26/2012CA2824757A1 Phenyl-isoxazol derivatives and preparation process thereof
10/25/2012US20120271361 Functionalized Nanodiamond Reinforced Biopolymers
10/25/2012US20120270955 Ophthalmic composition with a viscosity enhancement system having two different viscosity enhancing agents
10/25/2012US20120270953 Methods and compositions for the treatment of infection or infectious colonization of the eyelid, ocular surface, skin or ear
10/25/2012US20120270940 Closthioamides
10/25/2012US20120270939 Formulations and methods for treating amyloidosis
10/25/2012US20120270936 Composition and method for treatment of inflamation and infections of the genitalia, contraceptive and the prophylaxis of sexually transmitted diseases
10/25/2012US20120270935 Formulations
10/25/2012US20120270924 Oligomeric Compounds For The Modultion of HIF-1A Expression
10/25/2012US20120270921 Lipid Formulated Compositions and Methods for Inhibiting Expression of a Gene from the Ebola Virus
10/25/2012US20120270917 Adamantane analogs
10/25/2012US20120270909 Method of inhibiting harmful microorganisms and barrier-forming composition therefor
10/25/2012US20120270907 Therapeutic uses of nicotine
10/25/2012US20120270888 Pharmaceutical compositions of raltegravir, methods of preparation and use thereof
10/25/2012US20120270880 Pyrrolo [2,3-d] pyrazin-7-ylpyrimidine compounds
10/25/2012US20120270879 Heterocyclic Compounds As CCR1 Receptor Antagonists
10/25/2012US20120270877 IRE-1alpha INHIBITORS
10/25/2012US20120270874 Biaryl Compositions and Methods for Modulating a Kinase Cascade
10/25/2012US20120270864 2-quinolinone and 2-quinoxalinone-derivatives and their use as antibacterial agents
10/25/2012US20120270859 Indoline derivatives and their use in treating disease-states such as cancer
10/25/2012US20120270854 Antiviral Compounds
10/25/2012US20120270845 Compositions and Methods for Treating Chronic Inflammation and Inflammatory Diseases
10/25/2012US20120270828 Quadruple therapy useful for treating persons afflicted with the human immunodeficiency virus (hiv)
10/25/2012US20120270827 Indole Antiviral Compositions And Methods
1 ... 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 ... 1798